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The restless legs syndrome (RLS) is a neurological disor-
der characterized by an urgency to move the legs usually as-
sociated with unpleasant sensations in the lower limbs. The 
symptoms predominate at rest and at night, and they are re-
lieved by leg movements. It may be primary (idiopathic) or 
secondary to diverse conditions, such as pregnancy, end-
stage renal disease, iron deficiency anemia, peripheral neu-
ropathy, and Parkinson’s disease1.
RLS predominates in women and its prevalence in the 
general population is estimated to range from 5 to 15%. In 
Brazil, there are few clinical epidemiological studies of RLS2-4. 
In this context, our objective was to determine the clinical 
correlates of patients with RLS in a Brazilian tertiary sleep 
disorder center.
MetHODS
A retrospective case-record analysis was performed in 
patients with RLS who visited the outpatient Neuro-Sono 
Sleep Center at the Universidade Federal de São Paulo, from 
January, 2004, to December, 2010. The Neuro-Sono sleep 
clinic attends about six new cases per week, totaling 270 
new ones per year.
To be included in this study, patients had to fulfill the 
diagnostic criteria for RLS established by the International 
RLS Study Group (IRLSG)2. Basically, data collected were 
age at disease onset and at the time of evaluation, gender, 
race (white or non-white), years of school instruction, and 
RLS treatment. 
Neuro-Sono – Division of Sleep Disorders, Department of Neurology and Neurosurgery, Universidade Federal de São Paulo (UNIFESP), São Paulo SP, Brazil.
Correspondence: Luis Fabiano Marin; Rua Claudio Rossi 394; 01547-000 São Paulo SP - Brasil; E-mail: luisfabianom@gmail.com
Conflict of interest: There is no conflict of interest to declare.
Received 03 July 2011; Received in final form 06 December 2011; Accepted 13 December 2011
AbStrAct
Objective: To determine the clinical correlates of the restless legs syndrome (RLS) in a Brazilian sleep disorders center. Methods: We retro-
spectively studied 118 patients with RLS from January, 2004, to December, 2010. The analyzed variables were: age at disease onset, gender, 
race, years of school instruction, primary and secondary RLS, and treatment options. Results: Among the studied patients, 83.9% were wom-
en with a female/male sex ratio of 5:1. Mean age of the patients at symptom onset ± standard deviation was 41.7±17.9 years-old. The primary 
RLS was found in 85% of patients. The other 15% remainders consisted of secondary forms, and they were associated with neuropathy, iron 
deficiency anemia, end-stage renal disease, or Parkinson’s disease. Drug therapy for RLS was introduced in 67% of patients. Conclusions: 
Most patients presented primary RLS with an early disease onset. Further epidemiological studies are welcomed to provide better informa-
tion on secondary RLS in Brazil.
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reSuMO
Objetivo: Determinar as correlações clínicas da síndrome das pernas inquietas (SPI) em um centro brasileiro de distúrbios de sono. Métodos: 
Foram estudados retrospectivamente 118 pacientes com SPI atendidos entre janeiro de 2004 e dezembro de 2010. As variáveis analisadas 
compreendiam: idade ao início da doença, sexo, raça, escolaridade, SPI primária e secundária e tratamento da SPI. Resultados: Do total de 
pacientes estudados, 83,9% eram mulheres e a razão mulher∕homem foi de 5:1. A média de idade dos pacientes ± desvio padrão de quan-
do iniciaram sintomas da SPI foi de 41,7±17,9 anos. Oitenta e cinco por cento dos pacientes apresentaram SPI primária. Os restantes 15% 
apresentaram a forma secundária, que estava associada à neuropatia periférica, anemia por deficiência de ferro, insuficiência renal crônica 
e doença de Parkinson. Foi introduzida medicação para SPI em 67% dos pacientes. Conclusões: A maioria dos pacientes apresentou SPI pri-
mária com início precoce da doença. Mais estudos epidemiológicos são necessários para prover informações sobre as causas secundárias 
de SPI no Brasil.
Palavras-Chave: síndrome das pernas inquietas, síndrome das pernas inquietas, epidemiologia, Brasil.
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We have searched for secondary causes of RLS (iron de-
ficiency anemia, neuropathy, pregnancy, end-stage renal 
disease, and Parkinson’s disease). We considered with iron 
deficiency anemia those individuals who performed com-
plete blood count and who had a hypochromic microcytic 
anemia with low levels of hemoglobin (Hb<13 g∕dL for men; 
Hb<12 g∕dL for women). For the diagnosis of peripheral neu-
ropathy, it was necessary to establish clinically the disease 
and its confirmation by electrophysiological studies. End-
stage renal disease was diagnosed in patients who had crea-
tinine clearance <15 mL/min. or who were performing hemo-
dialysis. Two-tailed χ2 test was performed to access differences 
between age of symptoms onset in the primary versus second-
ary RLS Groups. Statistical significance was set at p<0.005. 
We investigated comorbid clinical conditions, such as 
arterial hypertension, diabetes mellitus, hypothyroidism, 
depression, smoking, alcohol consumption, fibromyalgia, 
and other rheumatic diseases taking into account data on 
medical files.
The clinical data recording over the seven year-protocol 
was carried out in a systematic manner, using a standard 
clinical protocol. Even though different physicians of varying 
degrees of experience participated on data collection, each 
case on the first consultation and subsequent follow-up was 
obligatorily discussed with a sleep-disorder specialist, due to 
the academic nature of our institution. Incomplete or poorly 
recorded files were excluded from the statistical analysis. 
This study protocol is part of a larger study on RLS, and 
it was approved by our local Ethical Committee (registration 
number=0850∕05).
reSultS
A total of 118 patients (women=83.9%; men=16.1%) ful-
filled the RLS diagnostic criteria of the IRLSG. The female 
to male ratio was 5:1, and the mean age at evaluation was 
52.4±16.4 years-old. Most patients were white (88%). The 
mean school instruction was 9±3.1 years-old. Only one pa-
tient had no school instruction. Overall, the mean body mass 
index (BMI) was 26.5±5.5 kg/m2. 
The range for age at onset in patients with RLS was con-
siderably wide (3 to 81 years-old) with mean age of 41.7±17.9 
years-old. Sixty-four patients (55%) had their age at onset of 
RLS symptoms before 45 years-old (early-onset disease). 
In 85% of the patients, we did not find secondary causes 
of RLS, while the remaining ones (15%) with RLS were asso-
ciated with peripheral neuropathy, iron deficiency anemia, 
end-stage renal disease, or Parkinson’s disease (Table 1). With 
respect to the etiology of neuropathy in the affected individu-
als, seven had diabetic neuropathy and one was of unknown 
cause. In the group of primary RLS, the average age at onset 
of RLS symptoms was 41.1±17.6 years-old, while in the group 
of secondary RLS, it was 45±19.3 years-old. We did not find 
significant differences regarding age of symptom onset in the 
primary versus secondary RLS Groups (p=0.637).
Drug therapy for RLS was introduced in 67% of our patients 
and included: pramipexole (n=52; 44%), ropinirole (n=3; 2.5%), 
levodopa (n=5; 4.2%), gabapentin (n=13; 11%), clonazepam 
(n=6; 5%), diazepam (n=1; 0.8%), oxcarbazepine (n=2; 1.7%), 
and carbamazepine (n=3; 2.5%). In our sample, most patients 
were taking only one medication for symptom control, but 
seven required one of the following associations: pramipexol 
plus gabapentin, gabapentin plus clonazepam, and pramipex-
ol plus levodopa. Particularly, the latter association was taken 
by our patients with Parkinson’s disease (n=3; Table 1).
The most frequent clinical comorbid conditions in our 
sample were: arterial hypertension (n=45; 38.1%), depression 
(n=35; 27.9%), hypothyroidism (n=18; 14.4%), diabetes (n=9; 
7.6%), and fibromyalgia (n=6; 5%). Smoking was found in 
5.9% of the patients (Table 2). 
Of all patients suspected of RLS, 26 were not included in 
this study because they did not fulfill the diagnostic criteria 
established by the IRLSG.
DiScuSSiON
In Brazil, there are few studies on epidemiological fea-
tures of RLS. Dantas et al. studied 32 Brazilian elderly sub-
jects and found a 15% prevalence of RLS, predominantly in 
females5. Moreover, Goffredo Filho et al. evaluated 176 pa-
tients on dialysis therapy and found a 14% frequency of RLS6. 
Alves et al., investigating RLS in 524 pregnant women, found 
a 13.5% prevalence7. Recently, Eckeli et al. interviewed 1,155 
individuals in the rural town of Cassia dos Coqueiros and es-
timated a 6.4% RLS prevalence4.
Causes Number of patients/ % of patients
Peripheral neuropathy 8/6.8
Iron deficiency anemia 6/5
Parkinson’s disease 3/2.5
End-stage renal disease 1/0.8
Table 1. Secondary causes of the restless legs syndrome.
Comorbid conditions Number of patients / % of patients
Arterial hypertension 45/38.1
Depression 35/27.9
Hypothyroidism 18/14.4
Diabetes mellitus 9/7.6
Smoking 8/5.9
Fibromyalgia 6/5
Table 2. Comorbid conditions in patients with the restless legs 
syndrome.
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Our study was performed in an outpatient center of sleep 
disorders, however the methodology used does not allow us 
to estimate prevalence or incidence rates. Even so, we dem-
onstrated a high predominance of RLS in females and in 
Caucasians (attributed as white skin color herein), which is 
consistent with previous epidemiological data of a higher 
prevalence of RLS in females and Caucasians8. 
Our data also disclosed a predominance of primary rath-
er than secondary RLS, and our patients with primary RLS 
had an earlier disease onset (mean age: 41.1±17.6 years-old). 
Literature in this issue has divided early RLS onset in those 
patients in whom the first symptoms began before 45 years-
old, and possibly they have a genetic and family component9. 
Secondary forms of RLS in our patients were associated with 
some conditions previously described1,2, and neuropathy was 
the most frequent condition (44.4%), followed by iron defi-
ciency anemia (33.3%).
Regarding the presence of clinical comorbidities in our 
patients, we found high frequency of arterial hypertension 
and depression. Previous studies have suggested a relation-
ship between RLS and arterial hypertension, but they did not 
find a clear association of hypertension as a risk factor for 
RLS10. On the other hand, epidemiological studies report a 
two to four risk of depressive disorder in patients with RLS 
compared with the healthy controls, suggesting an associa-
tion between both diseases11. 
Most patients in our study were taking medication 
to control the symptoms of RLS, suggesting a higher de-
gree of symptom severity. However, a shortcoming of our 
study, due to its retrospective methodology, was the lack 
of graduating patients’ RLS severity, alongside with a re-
ferral bias that tends to select more severe cases than in 
the general population.
In summary, our large series of RLS confirms the epi-
demiological data previously reported elsewhere for non-
Brazilian and Brazilian populations and contributes to 
better understand regional clinical characteristics of our 
RLS patients.
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